Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous fentanyl versus EMLA cream for pain reduction during medial branch block needling
IRCT20230702058645N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Drug Delivery Systems, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Facet Joint Disorder and lumbodynia (LBP) comparing EMLA cream control with Intravenous fentanyl (2 arms). Primary endpoints: Pain severity and Patient satisfaction rate. Started Apr 2025; status: completed.
02
Drugs
fentanyllidocaine + prilocaine
03
Conditions
Facet Joint Disorderlumbodynia (LBP)
Beyond the preview
Go deeper on IRCT20230702058645N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230702058645N2.